Knop, V.; Vermehren, J.; Petersen, Joerg et al.
Disease progression is affected by pattern of serum alanine aminotransferase dynamics in a cohort of patients with hepatitis B e antigen-negative chronic infection: 4 years follow-up of a prospective longitudinal study (ALBATROS study)JOURNAL OF HEPATOLOGY. Bd. 68. 2018 S. S496-S496
Teuber, G.; Sprinzl, M.; Hueppe, D. et al.
Durability of HBsAg loss during or after antiviral treatment in a predominantly middle European collectiveJOURNAL OF HEPATOLOGY. Bd. 68. 2018 S. S506-S506
Knop, Viola; Mauss, Stefan; Goeser, Tobias et al.
Dynamics of Liver Stiffness By Transient Elastography in Patients with Chronic Hepatitis C (HCV) Infection Receiving Direct Acting Antiviral Therapy-Results from the German Hepatitis C-Registry (DHC-R)HEPATOLOGY. Bd. 68. 2018 S. 424A-424A
Labenz, C.; Woerns, M. -A.
Editorial: covert hepatic encephalopathy-silent but seriousALIMENTARY PHARMACOLOGY & THERAPEUTICS. Bd. 48. H. 4. 2018 S. 480-481
Labenz, Christian; Schattenberg, Joern M.
Editorial: stepwise risk stratification for both F3 and F4 in NAFLD patients-authors' replyALIMENTARY PHARMACOLOGY & THERAPEUTICS. Bd. 48. H. 11-12. 2018 S. 1318-1319
Kremer, Andreas; Bowlus, Christopher L.; Neff, Guy W. et al.
Effect of Seladelpar on Pruritus in Primary Biliary Cholangitis: 26-Week Analysis of an Ongoing International, Randomized, Dose Ranging Phase 2 StudyHEPATOLOGY. Bd. 68. H. 6. 2018 S. 1464A-1465A
Dultz, Georg; Mueller, Tobias; Petersen, Joerg et al.
Effectiveness and Safety of Direct-Acting Antiviral Combination Therapies for Treatment of Hepatitis C Virus in Elderly Patients: Results from the German Hepatitis C RegistryDRUGS & AGING. Bd. 35. H. 9. 2018 S. 843-857
Persico, M.; Flisiak, R.; Abunimeh, M. et al.
Efficacy and safety of glecaprevir/pibrentasvir in renally-impaired patients with chronic hepatitis C virus genotype 1-6 infectionJOURNAL OF HEPATOLOGY. Bd. 68. 2018 S. S292-S292
Bowlus, Christopher L.; Neff, Guy W.; Aspinall, Richard et al.
Efficacy and Safety of Seladelpar, a Selective Peroxisome Proliferator-Activated Receptor Delta Agonist, in Primary Biliary Cholangitis: 52-Week Analysis of an Ongoing International, Randomized, Dose Ranging Phase 2 StudyHEPATOLOGY. Bd. 68. H. 6. 2018 S. 1446A-1447A
Doria, A.; Stohl, W.; Schwarting, A. et al.
Efficacy and Safety of Subcutaneous Belimumab in Anti-Double-Stranded DNA-Positive, Hypocomplementemic Patients With Systemic Lupus ErythematosusARTHRITIS & RHEUMATOLOGY. Bd. 70. H. 8. 2018 S. 1256-1264